Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

Jean Yves Blay; Camille Tlemsani; Maud Toulmonde; Antoîne Italiano; María Rios; Emmanuelle Bompas; Thibaud Valentin; Florence Duffaud; Louis‐Romée Le Nail; Sarah Watson; Nelly Firmin; Pascale Dubray‐Longeras; M. Ropars; Christophe Perrin; Alice Hervieu; Célèste Lebbé; Esma Saâda-Bouzid; Pauline Soibinet; F. Fiorenza; François Bertucci; P. Boudou; Gualter Vaz; Sylvie Bonvalot; Charles Honoré; Perrine Marec‐Bérard; Véronique Minard‐Colin; Morgane Cleirec; David Biau; Pierre Méeus; A. Babinet; Valérie Dumaine; S Carrière; M. Fau; Gauthier Decanter; F. Gouin; Carine Ngo; François Le Loarer; Marie Karanian; Alexandra Meurgey; Armelle Dufresne; Mehdi Brahmi; Claire Chemin-Airiau; Françoise Ducimetière; Nicolas Penel; Axel Le Cesne

doi:10.1016/j.ejca.2023.113454

Shared by

Jean Yves Blay

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

Article 2023 en

Authors

Jean Yves Blay
CT
Camille Tlemsani
MT
Maud Toulmonde

Abstract

1 min read

Although sharing close molecular alterations, SEF and LGFMS have a different natural history, clinical presentation and outcome, with a higher risk of metastatic relapse in SEF. Survival after relapse is longer than with other sarcomas, and similar for SEF and LGFMS.

Discussion(0)

No comments yet. Be the first to comment.

Sclerosing Epithelioid Fibrosarcoma (SEF) versus Low Grade Fibromyxoid Sarcoma (LGFMS): Presentation and outcome in the nationwide NETSARC+ series of 330 patients over 13 years

Abstract

Discussion(0)

Related publications

1928P Differential presentation and outcome of sclerosing epithelioid fibrosarcoma (SEF) vs low grade fibromyxoid sarcoma (LGFMS): The nationwide series of 330 patients in NETSARC since 2010

The Influence of HIV Infection on Clinical Presentation, Response to Treatment, and Outcome in Adults with Tuberculous Meningitis

Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.

Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study

No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years

Related publications

Article2023
1928P Differential presentation and outcome of sclerosing epithelioid fibrosarcoma (SEF) vs low grade fibromyxoid sarcoma (LGFMS): The nationwide series of 330 patients in NETSARC since 2010
Article2023

Article2005
The Influence of HIV Infection on Clinical Presentation, Response to Treatment, and Outcome in Adults with Tuberculous Meningitis
Article2005

Article2005
Multiple Myeloma (MM) in Young Patients (pts): Clinical Features and Outcome in 259 Patients Younger Than 40 Years in Comparison to 8,296 pts Aged ≥ 40 Years.
Article2005

Article2007
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A U.S.–Canadian multicenter study
Article2007

Article2011
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years
Article2011